Basilea Pharmaceutica Ltd (0QNA)
LSE
Closed
Oct 7, 2026
Day's Range
64.5052 wk Range
44.70Overview - 0QNA - Basilea Pharmaceutica Ltd
Key Statistics
Valuation
Enterprise Value
759.99M
P/E (Trailing)
‪76.11‬
PEG Ratio
‪-1.52‬
Price / Sales (TTM)
‪10.07‬
Price / Book
‪5.23‬
EV / EBITDA
‪12.47‬
Profitability
Profit Margin
‪21.17%‬
Operating Margin
‪26.89%‬
Return on Assets
‪13.68%‬
Return on Equity
‪39.45%‬
Ownership
Shares Outstanding
10.86M
Float
11.31M
Held by Insiders
‪0.61%‬
Held by Institutions
‪31.42%‬
Price stats
Beta
‪0.43‬
50-Day Avg
‪35.23‬
200-Day Avg
‪39.55‬
Dividends
Frequency
Quarterly
Market Cap - 0QNA - Basilea Pharmaceutica Ltd
Peers - 0QNA - Basilea Pharmaceutica Ltd
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0QNALSEBasilea Pharmaceutica Ltd744.56MMarket Cap+32.63%52-week change76.11P/E (Trailing)‪21.17%‬Profit Margin
- 0MGBLSEGenmab A/S198.39BMarket Cap+15.12%52-week change33.69P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated Common Stock128.96BMarket Cap+20.00%52-week change0.53P/E (Trailing)‪34.99%‬Profit Margin
- 0A45LSEModerna Inc.95.05BMarket Cap+87.31%52-week change72.95P/E (Trailing)‪11.32%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.79.08BMarket Cap+20.99%52-week change0.11P/E (Trailing)‪27.86%‬Profit Margin
- 0QW0LSEargenx SE49.68BMarket Cap+27.60%52-week change40.07P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA41.70BMarket Cap-23.88%52-week change120.47P/E (Trailing)‪6.45%‬Profit Margin
Profile Summary - 0QNA - Basilea Pharmaceutica Ltd
About
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company headquartered in Allschwil, Switzerland, founded in 2000 as a spin-off from F. Hoffmann-La Roche. With approximately 150 employees, it focuses on discovering, developing, and commercializing innovative anti-infective drugs to address severe…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
